Plain-language articles on antidepressants, medication reviews, and what to expect — written for patients, checked by a consultant psychiatrist. Articles awaiting that check say so.
Written by Claro's editorial team and medically reviewed by consultant psychiatrists, led by Dr. Jason Tan; articles awaiting review are marked as pending. Supported by Claro's advisory board of 10 clinical experts and a wider network of specialists.
How we write these guides
These articles are educational. They exist to help you understand what is typical on antidepressants between visits — not to diagnose, prescribe, or replace your clinician. We hold them to the same bar as the rest of Claro: named people, cited sources, and a clear limit on what we will claim.
Sources
We prefer primary evidence: clinical guidelines, peer-reviewed papers, and official public-health sources. We do not treat blogs, forums, or marketing copy as evidence. Each article lists the sources it used, with links, so you can read the same material.
Medical review
A consultant psychiatrist reviews every article. The reviewer checks that the claims match the evidence, that safety caveats are present, and that we have not slipped into advice. You will see the reviewer's name and credentials on each reviewed article. An article published before its review says "Medical review pending" and names no reviewer until the review is done.
When we ask other experts
Our advisory board — psychiatrists, a neuroscientist, nurse practitioner, therapists, and specialist clinicians — is the core of a wider network we draw on. When a topic needs a specialist view, we try to reach an expert who works in that exact area, and their job is to challenge the draft, not rubber-stamp it. Meet the advisory board.
Read the full editorial policy